Sinusitis Treatment: Azithromycin Study

We are testing whether a three-month course of azithromycin improves quality of life for adults with idiopathic purulent oedematous sinusitis. The study will compare its effects to a placebo and evaluate treatment tolerance.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Azithromycin
Azithromycin is an antibiotic substance used to treat common bacterial infections, especially respiratory, ear, skin, and some sexually transmitted infections.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Azithromycin

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Centre Hospitalier Universitaire De Bordeaux
33076
Bordeaux, France
Assistance Publique Hopitaux De Paris
75014
Maison Blanche, France
Sponsor: Centre Hospitalier Intercommunal Creteil
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.